Zostel asks SEBI to review Oyo's updated DRHP over litigation disclosure gaps
Zostel has urged SEBI to scrutinise Oravel Stays' updated DRHP, alleging incomplete disclosures on their ongoing dispute over ~7% equity. The challenge comes as Oyo pursues a ₹6,650 crore IPO with no offer-for-sale component.
What happened
Zostel has asked SEBI to review Oyo parent Oravel Stays' updated DRHP, alleging incomplete disclosures on their ongoing legal dispute over ~7% equity, as Oyo
Key facts
- 7% equity
- ₹6,650 crore
Why this matters
The unresolved Zostel litigation over ~7% equity is now a live regulatory flashpoint, signaling that clean cap-table and disclosure hygiene are prerequisites for any comparable pre-IPO positioning or deal structuring.
What to watch
- SEBI formal acknowledgment or observation letter on the DRHP
- Any court order or hearing date on the Zostel-Oyo equity dispute
- Revised DRHP filing with amended litigation disclosures
- Statements from anchor investors or lead bankers on timing
- Media leaks on internal IPO calendar shift
- Oravel/Oyo issues clarification stressing disputes are disclosed and sub judice, reaffirming IPO intent
- Zostel pursues parallel judicial remedy (Supreme Court/arbitration follow-up) to strengthen SEBI leverage
- Bankers quietly recalibrate the launch window pending SEBI's response
- Legal counsel adds/expands contingent-liability and risk-factor language in a subsequent DRHP update